Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs031200359Active, not recruiting
Randomised, open-label trial in coronary arteriosclerosis, type 2 diabetes mellitus (T2DM), hypertension (HTN) and 1 more (2 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Absolute changes in percent plaque volumes in non-target coronary lesions. Started Nov 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs031200359.